Skip to content

GRCE

Grace Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$1.88
−0.53%
Ask drillr

Leverage

Debt / equity
0.00x
Net debt / equity
-0.29x
Debt / assets
0.00x
Debt / EBITDA
0.00x
Net debt / EBITDA
0.54x

Liquidity & coverage

Current ratio
11.47x
Quick ratio
11.47x
Cash ratio
11.00x
Interest coverage
—
EBITDA / interest
—
Working capital
$13.1M

Cash & dividend

FCF / debt
—
Cash flow / debt
—
Dividend per share
—
Dividend yield
—
Dividend growth 1y
—

Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026